Axitinib/dexamethasone/nivolumabLack of efficacy and interstitial pneumonia: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1977卷 / 1期

关键词：

D O I：

10.1007/s40278-023-47135-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：61 / 61

相关论文

共 50 条

[1] NivolumabLack of efficacy and interstitial pneumonia: case report
Reactions Weekly, 2022, 1914 (1) : 357 - 357
[2] Ipilimumab/nivolumabLack of efficacy: 2 case reports
Reactions Weekly, 2022, 1907 (1) : 269 - 269
[3] Ipilimumab/nivolumabLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1946 (1) : 305 - 305
[4] Atezolizumab/Bevacizumab/NivolumabLack of efficacy: 2 case reports
Reactions Weekly, 2025, 2040 (1) : 129 - 129
[5] NivolumabLack of efficacy: 5 case reports
Reactions Weekly, 2023, 1963 (1) : 426 - 426
[6] Axitinib/sunitinibLack of efficacy: 2 case reports
Reactions Weekly, 2023, 1953 (1) : 86 - 86
[7] Infliximab/ipilimumab/nivolumabLack of efficacy and colitis: 2 case reports
Reactions Weekly, 2022, 1931 (1) : 314 - 314
[8] Binimetinib/Encorafenib/Ipilimumab/nivolumabLack of efficacy: 2 case reports
Reactions Weekly, 2025, 2050 (1) : 117 - 117
[9] Ipilimumab/nivolumabLack of efficacy and autoimmune colitis: 2 case reports
Reactions Weekly, 2024, 2035 (1) : 252 - 252
[10] NivolumabLack of efficacy and moderate/severe liver rejection: 2 case reports
Reactions Weekly, 2022, 1929 (1) : 504 - 504

← 1 2 3 4 5 →